These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24072337)

  • 1. Rationale and design of the EPISTEME trial: efficacy of post-stroke intensive rosuvastatin treatment for aortogenic embolic stroke.
    Ueno Y; Yamashiro K; Tanaka Y; Watanabe M; Shimada Y; Kuroki T; Miyamoto N; Daimon M; Tanaka R; Miyauchi K; Daida H; Hattori N; Urabe T
    Cardiovasc Drugs Ther; 2014 Feb; 28(1):79-85. PubMed ID: 24072337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosuvastatin may stabilize atherosclerotic aortic plaque: transesophageal echocardiographic study in the EPISTEME trial.
    Ueno Y; Yamashiro K; Tanaka Y; Watanabe M; Miyamoto N; Shimada Y; Kuroki T; Tanaka R; Miyauchi K; Daida H; Hattori N; Urabe T
    Atherosclerosis; 2015 Apr; 239(2):476-82. PubMed ID: 25702618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial.
    Underhill HR; Yuan C; Zhao XQ; Kraiss LW; Parker DL; Saam T; Chu B; Takaya N; Liu F; Polissar NL; Neradilek B; Raichlen JS; Cain VA; Waterton JC; Hamar W; Hatsukami TS
    Am Heart J; 2008 Mar; 155(3):584.e1-8. PubMed ID: 18294500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosuvastatin improves plaque morphology in cerebral embolism patients with normal low-density lipoprotein and severe aortic arch plaque.
    Kaneko K; Saito H; Takahashi T; Kiribayashi N; Omi K; Sasaki T; Niizeki T; Sugawara S; Akasaka M; Kubota I
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1682-9. PubMed ID: 24739590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive lipid lowering therapy with titrated rosuvastatin yields greater atherosclerotic aortic plaque regression: Serial magnetic resonance imaging observations from RAPID study.
    Yogo M; Sasaki M; Ayaori M; Kihara T; Sato H; Takiguchi S; Uto-Kondo H; Yakushiji E; Nakaya K; Komatsu T; Momiyama Y; Nagata M; Mochio S; Iguchi Y; Ikewaki K
    Atherosclerosis; 2014 Jan; 232(1):31-9. PubMed ID: 24401214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of the carotid plaque in human for all evaluations with aggressive rosuvastatin therapy (CHALLENGER trial): evaluation by magnetic resonance imaging.
    Miyauchi K; Takaya N; Hirose T; Ikeda F; Kawamori R; Ohishi H; Yoshida K; Yamamoto M; Arai H; Urabe T; Hattori N; Suzuki M; Maehara T; Sase K; Hatsukami TS; Yuan C; Daida H
    Circ J; 2009 Jan; 73(1):111-5. PubMed ID: 19057091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
    Catapano AL; Davidson MH; Ballantyne CM; Brady WE; Gazzara RA; Tomassini JE; Tershakovec AM
    Curr Med Res Opin; 2006 Oct; 22(10):2041-53. PubMed ID: 17022864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of the rosuvastatin pretreatment to reduce embolization during Carotid Artery Stenting trial.
    De Carlo M; Cortese B; Pennesi M; Misuraca L; Conte L; Pitì A; Petronio AS; Balbarini A
    J Cardiovasc Med (Hagerstown); 2014 Jul; 15(7):595-600. PubMed ID: 24922046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
    Glueck CJ; Aregawi D; Agloria M; Khalil Q; Winiarska M; Munjal J; Gogineni S; Wang P
    Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution and involution of atherosclerosis and its relationship with vascular reactivity in hypercholesterolemic rabbits.
    Ozaki MR; de Almeida EA
    Exp Toxicol Pathol; 2013 Mar; 65(3):297-304. PubMed ID: 22024507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study).
    Bays HE; Davidson MH; Massaad R; Flaim D; Lowe RS; Tershakovec AM; Jones-Burton C
    Am J Cardiol; 2011 Aug; 108(4):523-30. PubMed ID: 21596364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3).
    Simsek C; Garcia-Garcia HM; van Geuns RJ; Magro M; Girasis C; van Mieghem N; Lenzen M; de Boer S; Regar E; van der Giessen W; Raichlen J; Duckers HJ; Zijlstra F; van der Steen T; Boersma E; Serruys PW;
    EuroIntervention; 2012 Jun; 8(2):235-41. PubMed ID: 22717926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosuvastatin for cardiovascular prevention: too many uncertainties.
    Prescrire Int; 2009 Aug; 18(102):176. PubMed ID: 19746571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosuvastatin prevents aortic arch plaque progression and improves prognosis in ischemic stroke patients.
    Kaneko K; Saito H; Sasaki T; Sugawara S; Akasaka M; Kanaya T; Kubota I
    Neurol Res; 2017 Feb; 39(2):133-141. PubMed ID: 27915586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of rosuvastatin on 3-nitrotyrosine and aortic stiffness in hypercholesterolemia.
    Pirro M; Schillaci G; Mannarino MR; Savarese G; Vaudo G; Siepi D; Paltriccia R; Mannarino E
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):436-41. PubMed ID: 17134956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early impairment of left ventricular function in hypercholesterolemia and its reversibility after short term treatment with rosuvastatin A preliminary echocardiographic study.
    Talini E; Di Bello V; Bianchi C; Palagi C; Delle Donne MG; Penno G; Nardi C; Canale ML; Del Prato S; Mariani M; Miccoli R
    Atherosclerosis; 2008 Mar; 197(1):346-54. PubMed ID: 17631295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosuvastatin combined with ramipril significantly reduced atheroma volume by anti-inflammatory mechanism: comparative analysis with rosuvastatin alone by intravascular ultrasound.
    Han SH; Chung WJ; Kang WC; Lee K; Park YM; Shin MS; Ahn TH; Choi IS; Shin EK
    Int J Cardiol; 2012 Jul; 158(2):217-24. PubMed ID: 21295363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing hypercholesterolemia and preventing cardiovascular events in elderly and younger Chinese adults: focus on rosuvastatin.
    Wang Z; Ge J
    Clin Interv Aging; 2014; 9():1-8. PubMed ID: 24353409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.